Deep Creek Pharma
Deep Creek Pharma, a North Carolina-based software firm, innovates nanoparticle tech for colorectal cancer treatment.
Deep Creek Pharma, a North Carolina-based software firm, innovates nanoparticle tech for colorectal cancer treatment.
Official pages and third-party coverage in one index.
deepcreekpharma.com3 items across 2 mapped pages · Crawled Sep 25, 2026
Official pages and third-party coverage in one index
Deep Creek Pharma is an oncology therapeutics company spun out of the Wake Forest University School of Medicine, and is developing CF10, a next generation fluoropyrimidine. CF10 is engineered for direct tumor-active metabolite formation and designed to improve upon fluorouracil, the chemotherapy backbone used across colorectal cancer and other solid tumors. The Company is in late pre-clinical stage and intends for the first indication to be metastatic colorectal cancer (mCRC) with liver metastas
Deep Creek Pharma is an oncology therapeutics company spun out of the Wake Forest University School of Medicine, and is developing CF10, a next generation fluoropyrimidine. CF10 is engineered for direct tumor-active metabolite formation and designed to improve upon fluorouracil, the chemotherapy backbone used across colorectal cancer and other solid tumors. The Company is in late pre-clinical stage and intends for the first indication to be metastatic colorectal cancer (mCRC) with liver metastas
Deep Creek Pharma is an oncology therapeutics company spun out of the Wake Forest University School of Medicine, and is developing CF10, a next generation fluoropyrimidine. CF10 is engineered for direct tumor-active metabolite formation and designed to improve upon fluorouracil, the chemotherapy backbone used across colorectal cancer and other solid tumors. The Company is in late pre-clinical stage and intends for the first indication to be metastatic colorectal cancer (mCRC) with liver metastas